Monday, January 30, 2006

The overlapping stent choice

As mentioned in a recent post, the sirolimus-eluting CYPHER stent is the stent of choice in complex cases.

Now, the FDA has revised instructions for use of the CYPHER Sirolimus-eluting Coronary Stent. The labeling now reflects FDA's review of clinical trial data that suggests there is no increased risk of heart attack with the use of overlapping CYPHER Stents in comparison to bare metal stents. This labeling change is based on a retrospective analysis of several clinical studies of overlapping CYPHER Stents examining more than 900 patients. The CYPHER Stent is the only drug-eluting stent with this new label.

Overlapping stents are most often used in patients with complex coronary artery disease in which the blockage is too long for a single stent. Today, approximately 25 percent of stenting procedures involve the use of overlapping coronary stents.

The study data leading to the revised instructions.
The CYPHER site for more general information.
Surgical webcast of CYPHER stent implantation. (Click on View Archived Webcast on the right side of the page.) Highly recommended.


At 4:40 PM, January 31, 2006, Anonymous hbennett said...

Good news. Is it true that abstent makes the heart grow stronger?


Post a Comment

<< Home